title: RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity.
abstract: An oncogenic form of RHAMM (receptor for hyaluronan-mediated motility, mouse, amino acids 163-794 termed RHAMM(Delta163)) is a cell surface hyaluronan receptor and mitotic spindle protein that is highly expressed in aggressive human cancers. Its regulation of mitotic spindle integrity is thought to contribute to tumor progression, but the molecular mechanisms underlying this function have not previously been defined. Here, we report that intracellular RHAMM(Delta163) modifies the stability of interphase and mitotic spindle microtubules through ERK1/2 activity. RHAMM(-/-) mouse embryonic fibroblasts exhibit strongly acetylated interphase microtubules, multi-pole mitotic spindles, aberrant chromosome segregation, and inappropriate cytokinesis during mitosis. These defects are rescued by either expression of RHAMM or mutant active MEK1. Mutational analyses show that RHAMM(Delta163) binds to alpha- and beta-tubulin protein via a carboxyl-terminal leucine zipper, but in vitro analyses indicate this interaction does not directly contribute to tubulin polymerization/stability. Co-immunoprecipitation and pulldown assays reveal complexes of RHAMM(Delta163), ERK1/2-MEK1, and alpha- and beta-tubulin and demonstrate direct binding of RHAMM(Delta163) to ERK1 via a D-site motif. In vitro kinase analyses, expression of mutant RHAMM(Delta163) defective in ERK1 binding in mouse embryonic fibroblasts, and blocking MEK1 activity collectively confirm that the effect of RHAMM(Delta163) on interphase and mitotic spindle microtubules is mediated by ERK1/2 activity. Our results suggest a model wherein intracellular RHAMM(Delta163) functions as an adaptor protein to control microtubule polymerization during interphase and mitosis as a result of localizing ERK1/2-MEK1 complexes to their tubulin-associated substrates.
authors.affiliation: Department of Oncology and Biochemistry, London Regional Cancer Program, University of Western Ontario and London Health Sciences Center, London, Ontario, Canada.
authors.forename: Cornelia
authors.initials: C
authors.lastname: Tolg
authors.forename: Sara R
authors.initials: SR
authors.lastname: Hamilton
authors.forename: Lyndsey
authors.initials: L
authors.lastname: Morningstar
authors.forename: Jing
authors.initials: J
authors.lastname: Zhang
authors.forename: S
authors.initials: S
authors.lastname: Zhang
authors.forename: Kenneth V
authors.initials: KV
authors.lastname: Esguerra
authors.forename: Patrick G
authors.initials: PG
authors.lastname: Telmer
authors.forename: Len G
authors.initials: LG
authors.lastname: Luyt
authors.forename: Rene
authors.initials: R
authors.lastname: Harrison
authors.forename: James B
authors.initials: JB
authors.lastname: McCarthy
authors.forename: Eva A
authors.initials: EA
authors.lastname: Turley
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D016326:Extracellular Matrix Proteins / Q000172:deficiency / Q000235:genetics*; D005347:Fibroblasts / Q000166:cytology*; D018960:Hyaluronan Receptors / Q000235:genetics*; D007399:Interphase; D048369:MAP Kinase Kinase 1 / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D008870:Microtubules / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism*; D008938:Mitosis; D011485:Protein Binding; D008941:Spindle Apparatus / Q000378:metabolism*
chemical_list: D016326:Extracellular Matrix Proteins; D018960:Hyaluronan Receptors; C098946:hyaluronan-mediated motility receptor; D048052:Mitogen-Activated Protein Kinase 3; D048369:MAP Kinase Kinase 1